A. Modesto

882 citations
42 papers · 393 · 1 hit paper · h-index 12

Impact in

    • Head and Neck Cancer Studies
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • Lung Cancer Research Studies

Papers in

A. Modesto

40 papers receiving 392 citations

A. Modesto's Hit Papers

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse. 2025 · 18 citations
180Years since publication51015

Peers

A. Modesto
Comparison fields: 5 of 56
  • Otorhinolaryngology 55
  • Oncology 144
  • Pulmonary and Respiratory Medicine 81
  • Genetics 22
  • Surgery 88
Replace Mirjam Baanstra with:
Mirjam Baanstra Netherlands
Akimitsu Hiraki Japan
Prabhsimranjot Singh United States
Rubén Fragoso United States
Yong Bao China
Kristie Lawhorn United States
Wendong Gu China
Friederike Göke Germany
Huan-Huan Wang China
Lu‐Jun Zhao China
A. Modesto relative to Mirjam Baanstra Netherlands Mirjam Baanstra's profile →
Citations per field
00.5×3.3×
Mirjam Baanstra · 1×
Citations per year

Countries citing papers authored by A. Modesto

Since Specialization
Citations

This map shows the geographic impact of A. Modesto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Modesto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Modesto more than expected).

Fields of papers citing papers by A. Modesto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Modesto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Modesto. The network helps show where A. Modesto may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Modesto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Modesto Line = papers co-authored together A. Modesto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201780
2 201340
3 201834
4 202023
5 201722
6 202121
7
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
Hit paper breakdown →
202518
8 201215
9 201415
10 201713
11 202012
12 201911
13 20139
14 20228
15 20138
16 20207
17 20217
18 20215
19 20195
20 20174

About A. Modesto

A. Modesto is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Surgery, Oncology and Molecular Biology, having authored 42 papers that have together received 393 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (12 papers), Brain Metastases and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Esophageal Cancer Research and Treatment (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Research Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Advanced Radiotherapy Techniques (3 papers). The work is most often cited by research in Otorhinolaryngology (55 citations), Oncology (144 citations), Pulmonary and Respiratory Medicine (81 citations), Genetics (22 citations) and Surgery (88 citations). A. Modesto has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Jean‐Pierre Delord, Carlos Gomez‐Roca, S. Boulinguez, V. Sibaud, Nicolás Meyer, C. Chira, Léonor Chaltiel, Elizabeth Cohen‐Jonathan Moyal, M. Delannes and Jean Bourhis. Their work appears in journals such as Strahlentherapie und Onkologie, Melanoma Research, Journal of Clinical Oncology, Cancers and Clinical and Translational Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact